НовостиBenzingaHC Wainwright & Co. Reiterates Buy on Faeth Therapeutics, Maintains $60 Price Target HC Wainwright & Co. Reiterates Buy on Faeth Therapeutics, Maintains $60 Price Target Benzinga 2026.11.16 13:33 (GMT+0) Открыть на Benzinga Другие новости